224 related articles for article (PubMed ID: 31789920)
1. PPARγ and RhoBTB1 in hypertension.
Fang S; Sigmund CD
Curr Opin Nephrol Hypertens; 2020 Mar; 29(2):161-170. PubMed ID: 31789920
[TBL] [Abstract][Full Text] [Related]
2. The 2023 Walter B. Cannon Award Lecture: Mechanisms Regulating Vascular Function and Blood Pressure by the PPARγ-RhoBTB1-CUL3 Pathway.
Sigmund CD
Function (Oxf); 2024; 5(1):zqad071. PubMed ID: 38196837
[TBL] [Abstract][Full Text] [Related]
3. RhoBTB1 protects against hypertension and arterial stiffness by restraining phosphodiesterase 5 activity.
Mukohda M; Fang S; Wu J; Agbor LN; Nair AR; Ibeawuchi SC; Hu C; Liu X; Lu KT; Guo DF; Davis DR; Keen HL; Quelle FW; Sigmund CD
J Clin Invest; 2019 Mar; 129(6):2318-2332. PubMed ID: 30896450
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms regulating vascular tone by peroxisome proliferator activated receptor gamma.
Ketsawatsomkron P; Sigmund CD
Curr Opin Nephrol Hypertens; 2015 Mar; 24(2):123-30. PubMed ID: 25587903
[TBL] [Abstract][Full Text] [Related]
5. Cullin-3 regulates vascular smooth muscle function and arterial blood pressure via PPARγ and RhoA/Rho-kinase.
Pelham CJ; Ketsawatsomkron P; Groh S; Grobe JL; de Lange WJ; Ibeawuchi SR; Keen HL; Weatherford ET; Faraci FM; Sigmund CD
Cell Metab; 2012 Oct; 16(4):462-72. PubMed ID: 23040068
[TBL] [Abstract][Full Text] [Related]
6. Smooth Muscle Peroxisome Proliferator-Activated Receptor γ Plays a Critical Role in Formation and Rupture of Cerebral Aneurysms in Mice In Vivo.
Hasan DM; Starke RM; Gu H; Wilson K; Chu Y; Chalouhi N; Heistad DD; Faraci FM; Sigmund CD
Hypertension; 2015 Jul; 66(1):211-20. PubMed ID: 25916724
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory mechanisms of the vascular smooth muscle PPARγ.
Mukohda M; Ozaki H
J Smooth Muscle Res; 2021; 57(0):1-7. PubMed ID: 33658456
[TBL] [Abstract][Full Text] [Related]
8. Protective Role for Tissue Inhibitor of Metalloproteinase-4, a Novel Peroxisome Proliferator-Activated Receptor-γ Target Gene, in Smooth Muscle in Deoxycorticosterone Acetate-Salt Hypertension.
Ketsawatsomkron P; Keen HL; Davis DR; Lu KT; Stump M; De Silva TM; Hilzendeger AM; Grobe JL; Faraci FM; Sigmund CD
Hypertension; 2016 Jan; 67(1):214-22. PubMed ID: 26597823
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system.
Auclair M; Vigouroux C; Boccara F; Capel E; Vigeral C; Guerci B; Lascols O; Capeau J; Caron-Debarle M
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):829-38. PubMed ID: 23393388
[TBL] [Abstract][Full Text] [Related]
10. PPARγ is a gatekeeper for extracellular matrix and vascular cell homeostasis: beneficial role in pulmonary hypertension and renal/cardiac/pulmonary fibrosis.
Kökény G; Calvier L; Legchenko E; Chouvarine P; Mózes MM; Hansmann G
Curr Opin Nephrol Hypertens; 2020 Mar; 29(2):171-179. PubMed ID: 31815758
[TBL] [Abstract][Full Text] [Related]
11. PPARγ regulates resistance vessel tone through a mechanism involving RGS5-mediated control of protein kinase C and BKCa channel activity.
Ketsawatsomkron P; Lorca RA; Keen HL; Weatherford ET; Liu X; Pelham CJ; Grobe JL; Faraci FM; England SK; Sigmund CD
Circ Res; 2012 Nov; 111(11):1446-58. PubMed ID: 22962432
[TBL] [Abstract][Full Text] [Related]
12. Role of vascular smooth muscle PPARγ in regulating AT1 receptor signaling and angiotensin II-dependent hypertension.
Carrillo-Sepulveda MA; Keen HL; Davis DR; Grobe JL; Sigmund CD
PLoS One; 2014; 9(8):e103786. PubMed ID: 25122005
[TBL] [Abstract][Full Text] [Related]
13. Dominant negative PPARγ promotes atherosclerosis, vascular dysfunction, and hypertension through distinct effects in endothelium and vascular muscle.
Pelham CJ; Keen HL; Lentz SR; Sigmund CD
Am J Physiol Regul Integr Comp Physiol; 2013 May; 304(9):R690-701. PubMed ID: 23447133
[TBL] [Abstract][Full Text] [Related]
14. Role of peroxisome proliferator-activated receptor-γ in vascular muscle in the cerebral circulation.
De Silva TM; Modrick ML; Ketsawatsomkron P; Lynch C; Chu Y; Pelham CJ; Sigmund CD; Faraci FM
Hypertension; 2014 Nov; 64(5):1088-93. PubMed ID: 25185134
[TBL] [Abstract][Full Text] [Related]
15. Smooth Muscle-Targeted Overexpression of Peroxisome Proliferator Activated Receptor-γ Disrupts Vascular Wall Structure and Function.
Kleinhenz JM; Murphy TC; Pokutta-Paskaleva AP; Gleason RL; Lyle AN; Taylor WR; Blount MA; Cheng J; Yang Q; Sutliff RL; Hart CM
PLoS One; 2015; 10(10):e0139756. PubMed ID: 26451838
[TBL] [Abstract][Full Text] [Related]
16. Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease.
Marchesi C; Rehman A; Rautureau Y; Kasal DA; Briet M; Leibowitz A; Simeone SM; Ebrahimian T; Neves MF; Offermanns S; Gonzalez FJ; Paradis P; Schiffrin EL
Cardiovasc Res; 2013 Mar; 97(3):562-70. PubMed ID: 23250918
[TBL] [Abstract][Full Text] [Related]
17. Bcr kinase activation by angiotensin II inhibits peroxisome-proliferator-activated receptor gamma transcriptional activity in vascular smooth muscle cells.
Alexis JD; Wang N; Che W; Lerner-Marmarosh N; Sahni A; Korshunov VA; Zou Y; Ding B; Yan C; Berk BC; Abe J
Circ Res; 2009 Jan; 104(1):69-78. PubMed ID: 19023129
[TBL] [Abstract][Full Text] [Related]
18. PPARγ and retinol binding protein 7 form a regulatory hub promoting antioxidant properties of the endothelium.
Woll AW; Quelle FW; Sigmund CD
Physiol Genomics; 2017 Nov; 49(11):653-658. PubMed ID: 28916634
[TBL] [Abstract][Full Text] [Related]
19. Vascular smooth muscle cell peroxisome proliferator-activated receptor γ protects against endothelin-1-induced oxidative stress and inflammation.
Idris-Khodja N; Ouerd S; Trindade M; Gornitsky J; Rehman A; Barhoumi T; Offermanns S; Gonzalez FJ; Neves MF; Paradis P; Schiffrin EL
J Hypertens; 2017 Jul; 35(7):1390-1401. PubMed ID: 28234672
[TBL] [Abstract][Full Text] [Related]
20. Genetic interference with peroxisome proliferator-activated receptor γ in smooth muscle enhances myogenic tone in the cerebrovasculature via A Rho kinase-dependent mechanism.
De Silva TM; Ketsawatsomkron P; Pelham C; Sigmund CD; Faraci FM
Hypertension; 2015 Feb; 65(2):345-51. PubMed ID: 25385762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
